Smart Syringes Market Shows Strong Growth Driven by Infection Prevention and Immunization Programs

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Smart Syringes Market- (By Product (With Needle (Fixed, Exchangeable), Without Needle Bioalcohols), By Volume (Below 1000 μL, Above 1000 μL), By Application (Medical (Drug Delivery, Blood Sample Collection, Vaccination), Non -Medical use )), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

The Smart Syringes Market Size is valued at USD 67.29 Mn in 2023 and is predicted to reach USD 145.62 Mn by the year 2031 at a 10.21% CAGR during the forecast period for 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2010

Smart syringes are next-generation medical injection devices equipped with automatic inactivation features that significantly reduce the likelihood of needlestick injuries and lower the risk of transmitting blood-borne pathogens such as hepatitis B, hepatitis C, and HIV. These devices are increasingly being deployed in various clinical settings, including large-scale immunization programs, routine therapeutic drug delivery, and diagnostic blood collection. Rising global incidences of infectious diseases, together with the expansion of vaccination initiatives, are expected to support sustained growth in smart syringe adoption over the forecast period.

In addition, the growing focus on minimizing hospital-acquired infections and strengthening overall healthcare safety protocols is accelerating the shift toward safer injection systems. The expanding elderly population-known to have higher infection susceptibility due to declining immune function-further contributes to the demand for reliable and secure injection solutions.

Heightened awareness of occupational risks in healthcare environments, particularly the ongoing rise in needlestick injuries among clinical personnel, is also playing a pivotal role in shaping market dynamics. As these incidents present substantial concerns regarding potential disease transmission, healthcare facilities across both developed and emerging markets are increasingly prioritizing the integration of smart syringes to enhance workplace safety and improve patient care standards.

List of Prominent Players in the Smart Syringes Market:
• Becton, Dickinson and Co.
• B. Braun Melungeon AG
• Terumo Medical Corporation
• Baxter International, Inc
• Retractable Technologies, Inc
• Smith's Group Plc
• Merck & Company Inc.
• Medtronic Plc (Covidien)
• Unilife Corporation
• Revolutions Medical Corporation
• AdvaCare Pharma
• Cardinal Health
• Parker Hannifin Corp.
• Numedico Technologies Pty Ltd
• Thomas Scientific (U.S),
• McKesson Medical-Surgical Inc. (U.S)
• Sharps Technology Inc.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The increasing shift toward minimally invasive medical procedures is a primary driver propelling the demand for smart syringes. These devices are engineered with integrated safety mechanisms that help prevent needlestick injuries and reduce the transmission risk of blood-borne infections, including HIV and hepatitis B and C. Their expanding use across clinical applications-such as therapeutic drug administration, diagnostic blood collection, and large-scale immunization programs-is further strengthening market growth.

Supportive recommendations from global health agencies, including the World Health Organization (WHO), have accelerated adoption by emphasizing the importance of safe injection practices within healthcare environments. Additionally, the surge in healthcare activity during the COVID-19 pandemic, particularly within pediatric care, contributed to increased utilization of smart syringes. Government-backed vaccination initiatives aimed at high-risk populations from an early age are also expected to support rising demand across adult and elderly groups.

Challenges:
Despite their proven safety benefits, the higher cost of smart syringes presents a significant barrier to broader adoption, especially in price-sensitive and developing markets. Certain models remain competitively priced relative to conventional single-use syringes; however, advanced versions incorporating enhanced safety functionality may cost up to five times more. Such cost disparities can impede procurement in resource-constrained healthcare systems.

Furthermore, substantial capital requirements for the production and maintenance of smart syringe technologies, coupled with pricing variability influenced by continuous innovation, continue to limit market penetration. Over time, however, increased market competition and ongoing technological advancements are expected to help mitigate cost-related constraints.

Regional Trends:
North America is projected to maintain a leading position in the global smart syringes market due to its early adoption of advanced healthcare technologies and higher awareness of the risks associated with unsafe injection practices. In contrast, the Asia-Pacific region is positioned for rapid expansion, supported by rising investments in healthcare infrastructure, increased public and private sector funding, and a strong focus on improving clinical safety and operational efficiency.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2010

Recent Developments:
• In July 2022, Sharps Technology acquired the Hungarian syringe manufacturing facility of Safegard Medical for $2.5 Mn. Sharps intended to increase its manufacturing capacity and use the facility to help meet the increasing demand for its smart safety syringes, a market that is projected to reach $14 billion by 2026. The production of intelligent syringes, which are designed to eliminate inadvertent needlestick injuries, prevent needle reuse, and reduce vaccine and medication waste.
• In Mar 2021, Allied Telesis and Terumo Co., Ltd. have collaborated to provide effective location visualisation for medical IoT devices. Terufusion Smart Syringe Pumps were added as wireless devices to the network monitoring and management platform of Allied Telesis Vista Manager EX. On the network map, along with other network and IoT devices, they were then readily identifiable by a syringe pump icon, and their precise location was displayed.

Segmentation of Smart Syringes Market-
By Product-
• With Needle
o Fixed
o Exchangeable
• Without Needle Bioalcohols
By Volume
• Below 1000 μL
• Above 1000 μL
By Application-
• Medical
o Drug Delivery
o Blood Sample Collection
o Vaccination
• Non -Medical use
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/smart-syringes-market/2010

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.